The Consumer Product Safety Commission has scheduled a Commission vote on July 15, 2010 on a draft Federal Register notice announcing an opportunity for comment and a public hearing on August 11, 2010 concerning CPSC's agenda and priorities for fiscal year 2012.
On July 8, 2010, the Food and Drug Administration warned that Que She, marketed as an herbal weight loss supplement, contains active pharmaceutical ingredients not listed on the product label that could harm consumers, especially those with cardiovascular conditions. Advertised as “Slimming Factor Capsule” and as “an all-natural blend of Chinese herbs,” Que She contains: fenfluramine, propranolol, sibutramine, and ephedrine.
The Consumer Product Safety Commission is seeking comments on a petition it received1 requesting that the agency initiate a rulemaking to revise CPSC's standards regarding bunk beds.
The Consumer Product Safety Commission has announced a closed meeting on July 14, 2010, in which the staff will brief the Commission on various compliance matters.
In a July 7, 2010 Commission meeting, the Consumer Product Safety Commission moved another step closer to publishing Federal Register notices establishing requirements for CPSC to accredit third-party labs to test children’s carpets and rugs and children’s vinyl plastic film products1 for compliance with CPSC standards.